SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA 1SXP.F Peers
See (1SXP.F) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
1SXP.F | €28.65 | -0.52% | 4.3B | 32.19 | €0.89 | +0.56% |
PHIA.DE | €48.00 | N/A | 43.4B | 13.73 | €3.50 | +4.16% |
BTL.DE | €58.80 | N/A | 29.6B | 30.31 | €1.94 | N/A |
SRT.DE | €176.40 | -0.45% | 13.7B | 127.83 | €1.38 | +0.41% |
SRT3.DE | €219.20 | -0.95% | 13.6B | 160.00 | €1.37 | +0.33% |
AFX.DE | €58.25 | -2.43% | 5.1B | 32.91 | €1.77 | +1.01% |
FIE.DE | €55.80 | -1.06% | 4.7B | 30.83 | €1.81 | +1.77% |
GXI.DE | €64.05 | +5.00% | 2.2B | 28.09 | €2.28 | +2.05% |
MYD.DE | €26.72 | N/A | 2.2B | -256.92 | -€0.10 | N/A |
2B4.F | €23.16 | +0.52% | 1.5B | 136.24 | €0.17 | N/A |
Stock Comparison
1SXP.F vs PHIA.DE Comparison
1SXP.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1SXP.F stands at 4.3B. In comparison, PHIA.DE has a market cap of 43.4B. Regarding current trading prices, 1SXP.F is priced at €28.65, while PHIA.DE trades at €48.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1SXP.F currently has a P/E ratio of 32.19, whereas PHIA.DE's P/E ratio is 13.73. In terms of profitability, 1SXP.F's ROE is +0.17%, compared to PHIA.DE's ROE of +0.03%. Regarding short-term risk, 1SXP.F is more volatile compared to PHIA.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 1SXP.F.